Safety of hydrolysates in parenteral nutrition.
D000818:Animals; D001224:Aspartic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood; D001925:Brain Damage, Chronic / Q000139:chemically induced; D002364:Caseins / Q000008:administration & dosage / Q000009:adverse effects; D004285:Dogs; D005947:Glucose / Q000008:administration & dosage; D005971:Glutamates / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood; D006168:Guinea Pigs; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects; D007231:Infant, Newborn; D007279:Injections, Subcutaneous; D051379:Mice; D010288:Parenteral Nutrition; D011492:Protein Hydrolysates / Q000008:administration & dosage / Q000009:adverse effects*
D002364:Caseins; D005971:Glutamates; D011492:Protein Hydrolysates; D001224:Aspartic Acid; D005947:Glucose